
P442: SPINK2 PROTEIN EXPRESSION QUANTIFIED BY IMMUNOHISTOCHEMISTRY REFINES RISK STRATIFICATION AND PREDICTS THERAPY OUTCOMES IN AML
Author(s) -
Pitts H. A.,
Cheng C. K.,
Cheung J. S.,
Sun M. K. H.,
Ng M. H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844656.93622.d3
Subject(s) - medicine , immunohistochemistry , oncology , myeloid leukemia , cohort , daunorubicin , leukemia , pathology